GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

StemRIM 4599.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

116

+4.50%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−¥1.85bn

FY2017FY2026

Free cash flow

−¥1.62bn

FY2017FY2026

Shareholders' equity

¥5.71bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017
Revenue———¥2.35bn¥1.40bn¥2.10bn¥100.0m¥200.0m¥300.0m
Gross profit−¥38.4m−¥49.5m−¥44.3m¥2.30bn¥1.40bn¥2.10bn¥100.0m¥200.0m¥300.0m
Research and development¥1.50bn¥1.37bn¥1.44bn¥1.55bn¥1.51bn¥1.36bn¥639.7m¥452.8m¥348.6m
Operating income−¥2.00bn−¥1.97bn−¥2.08bn¥142.4m−¥593.7m¥415.7m−¥726.9m−¥375.1m−¥160.8m
Net income−¥1.85bn−¥1.93bn−¥2.02bn¥168.3m−¥582.4m¥347.8m−¥721.2m−¥323.8m−¥123.9m
Diluted earnings per share-29.76-31.05-32.872.76-9.886.10-13.92-5.21-1.99

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017
Total assets¥5.91bn¥7.52bn¥9.09bn¥10.72bn¥10.93bn¥11.29bn¥2.69bn¥1.92bn¥1.04bn
Cash and short-term investments¥5.38bn¥6.99bn¥8.41bn¥10.22bn¥10.17bn¥10.68bn¥2.50bn¥1.84bn¥904.3m
Total liabilities¥196.0m¥210.3m¥194.1m¥348.5m¥231.1m¥439.4m¥92.0m¥52.6m¥52.4m
Debt———¥531,000¥6.7m¥9.7m¥12.6m——
Shareholders' equity¥5.71bn¥7.31bn¥8.89bn¥10.37bn¥10.70bn¥10.85bn¥2.60bn¥1.87bn¥991.2m
Shares outstanding62m62m62m61m59m57m52m62m62m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥1.61bn−¥1.41bn−¥1.88bn¥1.14bn−¥519.6m¥575.4m−¥777.8m−¥261.0m−¥285.3m
Capital spending−¥7.6m−¥43.3m−¥2.4m−¥350,000−¥89.1m−¥153.0m−¥4.6m−¥5.0m−¥5.0m
Free cash flow−¥1.62bn−¥1.46bn−¥1.88bn¥1.13bn−¥608.7m¥422.4m−¥782.4m−¥266.0m−¥290.3m
Dividends paid———−¥3.1m—————

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Gross profit−¥6.8m−¥7.1m−¥11.3m−¥13.2m−¥13.5m−¥13.4m−¥11.3m−¥11.3m
Operating income−¥514.5m−¥491.4m−¥451.0m−¥542.0m−¥459.8m−¥445.7m−¥492.9m−¥573.2m
Net income−¥442.8m−¥480.0m−¥400.9m−¥527.7m−¥460.0m−¥420.7m−¥488.3m−¥560.4m
Diluted earnings per share-7.12-7.72-6.44-8.49-7.40-6.77-7.86-9.11
Total assets¥5.91bn¥6.36bn¥6.81bn¥7.08bn¥7.52bn¥7.94bn¥8.37bn¥8.67bn
Cash and short-term investments¥5.38bn¥5.71bn¥6.20bn¥6.39bn¥6.99bn¥7.25bn¥7.66bn¥8.02bn
Shareholders' equity¥5.71bn¥6.13bn¥6.57bn¥6.82bn¥7.31bn¥7.75bn¥8.16bn¥8.40bn

Financial ratios

Data as of 28 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin———98.0%100.0%100.0%100.0%100.0%100.0%
Operating margin———6.1%-8620.7%-42.4%19.8%-726.9%-187.6%
Net margin———7.2%-8479.7%-41.6%16.6%-721.2%-161.9%
Return on equity-32.4%-26.4%-22.7%1.6%-20.7%-5.4%———
Return on assets-31.3%-25.6%-22.2%1.6%-20.3%-5.3%———
Free cash flow yield-14.9%-12.8%-17.7%10.8%-13.6%-4.2%———
Revenue growth———10128.1%-98.4%-33.3%2000.0%-50.0%-33.3%
Earnings growth-4.0%-4.6%-1301.2%-108.6%234.5%-267.5%———
Current ratio70.97x83.35x131.47x47.99x128.96x119.80x———
Debt to equity———0.00x0.00x0.00x0.00x0.00x—
Equity ratio96.7%97.2%97.9%96.7%97.8%97.9%———
Interest coverage——-2076083.00x2455.03x-14147.77x-2711.09x1404.44x-2390.99x—
R&D as a share of sales———66.0%6114.9%108.1%64.6%639.7%226.4%
Buybacks as a share of market value-0.1%-1.0%-0.9%-2.4%-1.1%-3.4%———

Growth per year

Compound annual rate

3 years5 years10 years
Operating income—27.5%—
Net income—26.0%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-4.2-8.5-9.6209.3-27.5-89.2105.1-66.1
Price to sales———15.0—37.117.4476.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.